Background: Coronary computed tomography angiography (CCTA) is a well-known method for evaluating anatomic coronary stenosis, but the reliability of CCTA to predict cardiovascular events is an issue of controversy. Materials and Methods: In this prospective observational study, 58 patients with acute chest pain and low-to-moderate risk were selected and CCTA was performed on them. During follow up, the occurrence of major adverse cardiac events (MACE), defi ned as, cardiac death, myocardial infarction or coronary revascularization, were evaluated. Sensitivity, specifi city, and positive and negative predictive values of CCTA for the occurrence of MACE, at the six-month follow up, were also evaluated. Results: A total of nine (15.5 %) were positive in terms of the MACE criteria and they all had positive CCTA results. It seemed that there was 100% sensitivity for CCTA in predicting the occurrence of MACE. Forty-nine patients had no MACE, among whom 48 patients had negative CCTA. Th e specifi city of CCTA in predicting the occurrence of MACE was 98%. All patients with positive CCTA showed signifi cant stenosis in angiography.
the first diagnostic step. Most cardiac centers are focused on stress survey (exercise treadmill test, myocardial perfusion imaging or stress echo) to look for functional ischemia. However, these are indirect methods and also suffer from high false positive and false negative results. Several studies have tried to determine diagnostic tests that can predict early and late prognosis of these patients. [5] Coronary computed tomography angiography is a new method for evaluating MACE, which is defi ned as cardiac death, myocardial infarction or coronary revascularization. For example, in one study, CCTA, when compared with invasive coronary angiography, has shown high sensitivity and specificity in the detection of clinically signifi cant coronary artery disease. It is proposed that CCTA has a high negative predictive value for ruling out the acute coronary syndrome (ACS) and predicting major adverse cardiac events in patients with acute chest pain.
INTRODUCTION
The evaluation of patients with acute chest pain, a discomfort with a squeezing pressure or burning sensation in the substernal or pericardial or pericardial region, is one of the major issues in medicine. The percentage of people with chest pain, who visit the Emergency Department, is increasing. Emergency physicians should have extreme caution when evaluating these patients. The shortterm mortality rate of patients who are wrongly discharged from the Emergency Department is about 25%. [1] It is believed that about 2-8% of the patients who are discharged from the Emergency Department have unstable angina or myocardial infarction. [2] Therefore, observation of all patients presenting to the Emergency Department with acute chest pain does not seem logical and economical. Based on the mentioned information, we need reliable diagnostic tests to evaluate these patients and risk-stratify them in the Emergency Departments. Coronary Artery Disease (CAD) for predicting MACE and mortality. These studies have proposed that patients with severe CAD, such as stenosis, have a signifi cant risk of a worse outcome. They are long-term retrospective observational cohorts, where CT results have been employed to guide management. [10] [11] [12] [13] [14] Although there have been some studies on the importance of CCTA, no study has evaluated this issue in a one-year follow-up of patients for MACE.
The aim of this study is to evaluate the diagnostic value of CCTA in determining the prognosis of patients with low-to-intermediate risk of acute chest pain in terms of the incidence of MACE.
MATERIALS AND METHODS

Study design and patients
This was a prospective descriptive study, which was conducted in a teaching hospital (St. Alzahra Hospital, Isfahan, Iran) during 2011-2012. This study was approved by the local ethical commi ee, and patients enrolled in the study a er signing a consent form (Research Project Number 390357).
Procedures
A total of 58 consecutive patients with acute chest pain and low-to-moderate risk [defi ned in Table 1 ], admi ed to the University Referral Teaching Hospital, the Alzahra Hospital, were evaluated. The exclusion criteria included: Stable arrhythmias, hemodynamic instability, clinical history of drug allergy, renal failure, pregnant women or women in childbearing age who did not use preventive method, β-Blocker contraindications, and a recent diagnosis of coronary disease (less than a month), which all were asked in a questionnaire. After taking the history and a er clinical evaluation, all the patients underwent CCTA. Invasive angiography was performed on the patients who had coronary artery stenosis of more than 50% in their CCTA. We also evaluated changes in cardiac enzymes. Cardiac enzymes (CPK MB, troponin) were checked serially every three hours. An EKG was performed on admission and repeated every 20 minutes, for one hour. Subsequently, the patients were under cardiac monitoring during hospitalization.
All the patients were followed up for one year. The frequency of MACE criteria were evaluated, to determine the value of CCTA in determining the prognosis of the patients. MACE was defined as death, myocardial infarction, unstable angina, and cases that required target vessel revascularization (TVR). Sensitivity, specifi city, and positive and negative predictive values of CCTA for the occurrence of MACE, at follow-up, were calculated. The results were reported by the cardiologist and follow-up was performed by the Emergency Medicine specialist. SPSS 20 was used for statistical analysis. For prediction of specifi ty and sensitivity, the McNemar test was used.
RESULTS
F i y-eight patients with a mean age of 56.5 ± 10.4 years (range: 40-87) were evaluated. MACE was more common in males (56.9%. The clinical and paraclinical data of patients are listed in Table 2 . Ten (17.2%) patients had more than50% coronary stenosis on CCTA (positive CCTA). Invasive coronary angiography confi rmed it for eight patients. During the follow-up period, nine (15.5%) patients experienced MACE [ Table 3 ]. Al l nine patients had positive CCTA. Also among 49 patients, who had no MACE, 48 patients had negative CCTA. The sensitivity, specifi city, and positive and negative predictive values of CCTA in predicting the occurrence of MACE was: 100, 98, 90, and 100%, respectively. The mean duration of hospitalization was 34.63 ± 21.50 hours. The mean of follow up was 14 months (range 6 to 22 months). No mortality was observed. 
DISCUSSION
This study showed that the sensitivity and negative predictive value of CCTA for the occurrence of MACE criteria was 100%. Besides, negative CCTA (coronary stenosis below 50%) can predict that MACE will not occur for the next six months.
Min et al. [10] found that stenosis over 70% could be a good predictor for the occurrence of MACE. This study was conducted on 172 patients, who were followed for an average of 22 months. The incidence of MACE criteria was signifi cantly greater in the group with coronary artery stenosis, as compared to the group that did not have stenosis. In our study, we did not compare two groups with positive and negative CCTA, but among those who had negative CCTA, no one had MACE, and all those with MACE had positive CCTA.
Hollander et al., [4] in a study on 54 patients with low-risk acute chest pain, reported the incidence of cardiovascular events in a 30-day follow-up; in this study all 54 patients underwent CCTA and patients who reported negative CCTA results were immediately discharged from the Emergency Department. Within 30 days, they were followed for occurrence of death and myocardial infarction. Approximately 46 of these patients were discharged from the Emergency Department a er CCTA, and none had cardiac complications at 30 days. The results of this study showed that in patients with low-risk acute chest pain, CCTA could grant permission to discharge the patients quickly. In our study, the patients were followed for a longer period our results were consistent with their results, which showed that none of the patients with negative CCTA had MACE.
Hoff mann et al. [8] studied CCTA in comparison with the standard method in patients with acute coronary syndrome. In this multicenter trial, 1000 patients with the acute coronary syndrome, who had no evidence of ischemia on EKG or troponin, were evaluated. The primary objective of this study was the length of stay in hospital.
The other objective of this study was the incidence of MACE at 28 days and discharge from the Emergency Department. The duration of hospitalization in the group that underwent CCTA was 7.6 hours less than the group that was treated with the standard method. The number of patients who were discharged directly from the Emergency Room in the CCTA group was signifi cantly more than that in the standard group. No signifi cant diff erence in the incidence of MACE was found in both groups a er 28 days and also the mean hospital costs were similar in both groups. The result of this study showed that usage of CCTA for triage of patients presenting to the Emergency Department with ACS symptoms could improve the clinical decision. Our study was smaller in sample size than that of Hoff man et al. and also we did not perform a comparison for evaluation of patients with acute chest pain, with the standard method and CCTA, in our hospital. Our study only described the incidence of MACE in patients who underwent CCTA and concluded that a negative CCTA result in patients with acute chest pain and low and intermediate risk, could strongly predict that MACE would not occur.
Schle et al. [11] studied the two-year prognostic value of a cardiac CT scan, to predict the occurrence of MACE in patients presenting to the Emergency Department with acute chest pain. In their study 368 patients, with a mean Some other studies showed that in diff erent patients the absence of CAD by CT, predicted that MACE would be absent in a follow-up period of ≤60 months. [13, 14, 16] In another study, the evaluation of patients presenting to the Emergency Department with acute chest pain was done with CCTA. In this observational study of 368 patients, with a mean age of 53 years, 31 patients (8%) patients had ACS. Among them, 50% of the patients were free of coronary heart disease, 31% had non-obstructive coronary disease, and 19% had signifi cant coronary artery narrowing. In this study, the sensitivity and negative predictive value for ACS in case of negative CCTA was 100%. The fi ndings showed that 50% of the patients with low and intermediate risk did not have ACS, so the immediate performance of CCTA in these patients could help in clinical decision-making, however, besides calculating the sensitivity and specifi city, and positive and negative predictive values of CCTA, the likelihood ratios were calculated for this test. [12] We only studied the sensitivity and specifi city, and predictive value of this diagnostic technique; the sensitivity and the negative predictive value of CCTA in our study was 100% too. The Rule out Myocardial Infarction Using Computer Assisted Tomography (ROMICAT) trial was a prospective, doubleblind observational study, which included 368 patients with acute chest pain and a low-to-intermediate risk of ACS. In this trial, 50% of the patients had no coronary atherosclerosis on CT, did not have ACS during hospitalization or MACE during the 60-month follow up. [17] Thus, the normal fi nding on CT, with no evidence of coronary atherosclerosis, changed the disposition decision of physicians in the patient population. [18] Also the long-term eff ects of CT radiation in terms of more widespread use of this equipment should be kept in mind and evaluated before any guideline change. [19] Data from the previous trial and other observational studies showed that cardiac CT angiography is a valuable diagnostic evaluating tool in the early triage of patients with chest pain [20] [21] [22] [23] [24] [25] however, multicenter, randomized trials in ED patients are needed to answer whether this study is a cost-eff ective strategy when compared with the standard modalities.
In conclusion, it se ems that CCTA allows us to predict the prognosis of patients with acute chest pain and low-tomoderate risk, in terms of MACE occurrence.
Limitations of the study: This study was a single center study with a limited number of patients and a limited time of follow up. For more robust recommendations we still need long-term follow ups and larger studies, with more patients included, in more than one center.
